Association between circulatory complement activation and hypertensive renal damage: a case-control study

Zhongli Wang1, Tingting Zhang2, Xinyu Wang3

  • 1Department of Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, China.

Renal Failure
|June 14, 2024
PubMed

Insights

Abnormal complement alternative pathway (AP) activation, indicated by elevated C3 and AP50 and reduced CFH, is linked to hypertensive renal damage. These complement factors are independent risk factors for developing and worsening kidney damage in hypertension.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiovascular Research

Background:

  • Hypertensive renal damage is a significant complication of essential hypertension.
  • The role of the complement system, particularly the alternative pathway (AP), in this damage is not fully understood.

Purpose of the Study:

  • To investigate the potential role of complement system activation, specifically the AP, in the pathogenesis of hypertensive renal damage.
  • To identify specific complement factors associated with hypertension and renal damage.

Main Methods:

  • Serum levels of complement C3, complement Factor H (CFH), and AP activation (AP50) were measured.
  • Participants included patients with essential hypertension and renal damage (RD), essential hypertension without renal damage (NRD), and healthy controls.
  • Multifactorial logistic regression analysis was used to identify independent risk factors.

Main Results:

  • Serum C3 and AP50 levels increased progressively from healthy controls to NRD to RD.
  • CFH levels were significantly lower in patients with RD compared to NRD and healthy controls.
  • Elevated C3, elevated AP50, and decreased CFH were identified as independent risk factors for the development and progression of hypertensive renal damage, alongside age and BMI.

Conclusions:

  • Abnormal activation of the complement system, particularly the AP, is implicated in the pathogenesis of hypertensive renal damage.
  • Complement factors C3, AP50, and CFH serve as potential biomarkers and therapeutic targets for managing hypertensive renal damage.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
611
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
619
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
567
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
1.9K